Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | Antiplatelet and Anticoagulation Therapies

March 14, 2017 — More than 80 percent of stroke patients with a history of atrial fibrillation either received not ...

Home March 14, 2017
Home
Technology | Stents

March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc. first-in-class Cobra PzF ...

Home March 02, 2017
Home
News | Heart Failure

February 22, 2017 — The American College of Cardiology (ACC), Haymarket Medical Education (HME) and myCME have joined ...

Home February 22, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

February 9, 2017 — Janssen Research & Development LLC (Janssen) announced that the Phase 3 COMPASS trial is stopping ...

Home February 09, 2017
Home
News | Pharmaceuticals

February 7, 2017 — GE Healthcare’s Life Sciences business announced in January that it acquired Rapidscan Pharma ...

Home February 07, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

January 17, 2017 — Warfarin is a commonly prescribed blood thinner used to prevent harmful blood clots. However, the ...

Home January 17, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

January 11, 2017 — For patients with atrial fibrillation, the most common form of heart arrhythmia, a main goal of ...

Home January 11, 2017
Home
Feature | Point of Care Testing | Ravi Chawat

Point of care testing devices are gaining widespread approval for prompt medical diagnoses, especially in cardiology and ...

Home December 30, 2016
Home
News | Pharmaceuticals

December 28, 2016 — Cimaglermin, a new experimental drug, may help restore cardiac function after heart failure ...

Home December 28, 2016
Home
News | Pharmaceuticals

December 13, 2016 — Coupling data mining of adverse event reports and electronic health records with targeted laboratory ...

Home December 13, 2016
Home
INRatio, Alere, Abbott, I and R testing, INR testing
Feature | Point of Care Testing

December 7, 2016 — Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the substantial ...

Home December 07, 2016
Home
Videos | TCT

DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology technologies he ...

Home November 18, 2016
Home
News | Atrial Fibrillation

November 15, 2016 — Atrial fibrillation patients who use warfarin to lower risk of stroke are at higher risk of ...

Home November 15, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

November 14, 2016 — Two differing blood clot prevention medications are just as safe and effective for patients ...

Home November 14, 2016
Home
Technology | Point of Care Testing

November 10, 2016 — Siemens Healthineers announced U.S. Food and Drug Administration (FDA) 510(k) clearance for a hand ...

Home November 10, 2016
Home
Subscribe Now